Welcome to the website of DSM Sinochem Pharmaceuticals!

DSM Sinochem Pharmaceuticals (DSP) is the global leader in sustainable antibiotics, next generation statins and anti-fungals.

We develop, produce and sell raw materials, intermediates, active pharmaceutical ingredients (API) and drug products (DP).

Our employees worldwide work together to deliver cutting edge generics solutions that help to keep customers ahead of the

Headquartered in Singapore, the group has operations in China, India, Egypt, the Netherlands, Spain, the US and Mexico.


DSM Sinochem Pharmaceuticals Wins European Responsible Care Award For Work in Sustainable Antibiotics
DSM Sinochem Pharmaceuticals (DSP) has won the prestigious CEFIC European Responsible Care Award in the Product Stewardship Category for its Sustainable Antibiotics program. The program is DSP’s own initiative to promote the responsible manufacturing and use of antibiotics. Readmore
DSM Sinochem Pharmaceuticals offers Rosuvastatin API with CEP and Finished Dosage formulations using own API 
DSM Sinochem Pharmaceuticals (DSP) announced that it has been granted an update of the Certification of Suitability to the Monograph of the European Pharmacopoeia (CEP) for its generic Rosuvastatin Active Pharmaceutical Ingredient (API). Readmore

On September 21, DSM Sinochem Pharmaceuticals (DSP), one of the world’s leading global generic antibiotics manufacturers, will take part in the United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR) in New York. Ahead of the meeting, DSP and 12 other leading pharmaceutical companies presented a comprehensive roadmap laying out joint commitments to combat the threat of AMR. Readmore